| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $85.1B | $86.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $21.3B | $19.7B | $19.1B | $13.2B | $21.5B | $3.3B | $19.5B | $22.4B |
| EPS (Basic) | $6.34 | $5.43 | $4.88 | $3.17 | $4.99 | $0.42 | $4.08 | $4.31 |
| EPS (Diluted) | $6.26 | $5.37 | $4.83 | $3.14 | $4.95 | $0.41 | $4.05 | $4.28 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2148.6B | $1929.8B | $1932.5B | $1881.0B | $1948.1B | $1955.2B | $1927.6B | $1895.9B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $1965.6B | $1748.8B | $1745.0B | $1699.1B | $1758.0B | $1769.2B | $1739.6B | $1698.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $181.1B | $179.1B | $185.7B | $179.9B | $187.6B | $184.9B | $187.1B | $196.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-19.0B | $3.0B | $40.4B | $27.0B | $-11.5B | $2.1B | $6.7B | — |
| Investing Cash Flow | $-187.9B | $-15.7B | $16.0B | $-42.5B | $-7.6B | $122.6B | $-29.6B | — |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $177.6B | $-21.5B | $20.5B | $-59.6B | $-11.2B | $-1.2B | $-9.1B | — |